Management of Uveitis in Spondyloarthropathy: Current Trends

The Permanente Journal

Nikhil Gupta, MBBS, MD¹ 

关键词: Management of Uveitis in Spondyloarthropathy Current Trends;   

DOI  :  10.7812/TPP/17-041E-pub: 12/15/2017ABS" />

学科分类：医学（综合）

来源: Permanente Medical Group

【 摘 要 】

Spondyloarthritis is a chronic inflammatory disease predominantly affecting joints of the axial skeleton. However, as many as 50% of patients with this disease may have extra-articular manifestations, which include uveitis; psoriasis; inflammatory bowel disease such as Crohn disease or ulcerative colitis; cardiovascular manifestations in the form of conduction abnormalities, atherosclerosis, or valvular heart disease; pulmonary involvement; and rarely renal involvement. Uveitis occurs in 25% to 40% of patients with spondyloarthritis. Management of uveitis is crucial to prevent morbidity caused by vision loss and secondary complications. Treatment ranges from local therapies to systemic drugs and varies depending on the severity and response to treatment. Categories of medical treatment include nonsteroidal anti-inflammatory agents, corticosteroids, and steroid-sparing agents. Biologic therapies such as antitumor necrosis factor agents act early in the disease process and have revolutionized the field of rheumatology, including management of uveitis. This review will focus on the management of ophthalmic manifestations in spondyloarthropathies.

【 授权许可】

Unknown